Expertise in
1
conditions

Richard A. Noble

Newcastle Upon Tyne, ENG, GB 
Expertise in
1
conditions
Newcastle Upon Tyne, ENG, GB 

Overview

Richard Noble practices practicing medicine in Newcastle Upon Tyne, United Kingdom.

Mr. Noble is highly rated in 1 condition, according to our data. His clinical expertise encompasses Polycythemia Vera, Diffuse Large B-Cell Lymphoma (DLBCL), Burkitt Lymphoma, and B-Cell Lymphoma.

He is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Newcastle Upon Tyne, ENG NE17RU, United Kingdom
Other Locations
London, ENG, United Kingdom
Truro, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Long-term Study Evaluating the Effect of Givinostat in Patients With JAK2V617F Positive Chronic Myeloproliferative Neoplasms
Long-term Study Evaluating the Effect of Givinostat in Patients With JAK2V617F Positive Chronic Myeloproliferative Neoplasms
Enrollment Status: Active_not_recruiting
Publish Date: April 30, 2025
Intervention Type: Drug
Study Drug: Givinostat
Study Phase: Phase 2
A Two-part Study Top Assess the Safety and Preliminary Efficacy of Givinostat in Patients With JAK2V617F Positive Polycythemia Vera
A Two-part Study Top Assess the Safety and Preliminary Efficacy of Givinostat in Patients With JAK2V617F Positive Polycythemia Vera
Enrollment Status: Completed
Publish Date: July 30, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

11 Total Publications

Covalent Alkynylpyridopyrimidinones Targeting Cysteine 775 of the Epidermal Growth Factor Receptor Overcome Resistance to Current Therapies.
Covalent Alkynylpyridopyrimidinones Targeting Cysteine 775 of the Epidermal Growth Factor Receptor Overcome Resistance to Current Therapies.
Journal: Journal of medicinal chemistry
Published: December 23, 2025

Frequently Asked Questions about Richard A. Noble

Is Richard A. Noble a top-rated expert for Polycythemia Vera?

MediFind is an objective health platform that identifies experts based on real-world data. Richard A. Noble is classified as an Advanced expert for Polycythemia Vera, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Richard A. Noble participate in research or clinical trials?

Yes. Richard A. Noble has published 11 articles and abstracts on conditions like Polycythemia Vera. You can view a list of Richard A. Noble's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Noble's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile